Cybersecurity experts are warning Australia's impending social media ban could lead to a rise in a new type of scam — with ...

US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL: Princeton, New Jersey Wednesday, August 6, 2 ...